Regulatory News for September 2013

Regulatory News Archive

New study debunks the myth of a rising medicines bill New study debunks the myth of a rising medicines bill

ABPI Chief Executive Stephen Whitehead has welcomed the publication of a ground-breaking new UK NHS Medicines Bill projection by the Office of Health Economics (OHE) published in Pharmaeconomics. This study corrects common misconceptions by clearly showing that NHS spending on medicines is under control.

Innovators working hard to avoid patent exclusions in the US Innovators working hard to avoid patent exclusions in the US

By Adrian Tombling, partner and patent attorney at Withers & Rogers (www.withersrogers.com).Just 18 months after a controversial patent ruling in the US, global pharmaceutical companies and manufacturers of diagnostic methods are working hard to overcome some of the nonsensical exclusions that now apply when seeking commercial protection there.

Britons want world class access to new cancer treatments, finds survey Britons want world class access to new cancer treatments, finds survey

A new survey has found that four in five adults want the NHS to offer levels of access to treatment at least comparable with other countries. Half believe the NHS should be a world leader in the treatments available to patients and should pay for all treatments regardless of how much they cost, going beyond international standard practice

Reed Elsevier announces Environmental Challenge winners

Reed Elsevier has announced the winners of the 2013 Reed Elsevier Environmental Challenge, which supports innovative solutions to improve sustainable access to safe water and sanitation.